DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype
(2022) In JCI Insight 7(19).- Abstract
Cellular stress contributes to the capacity of melanoma cells to undergo phenotype switching into highly migratory and drug tolerant dedifferentiated states. Such dedifferentiated melanoma cell states are marked by loss of melanocyte specific gene expression and increase of mesenchymal markers. Two crucial transcription factors, MITF and SOX10, important in melanoma development and progression have been implicated in this process. In this study we describe that loss of MITF is associated with a distinct transcriptional program, MITF promoter hypermethylation and poor patient survival in metastatic melanoma. From a comprehensive collection of melanoma cell lines, we observed that MITF methylated cultures were subdivided in two distinct... (More)
Cellular stress contributes to the capacity of melanoma cells to undergo phenotype switching into highly migratory and drug tolerant dedifferentiated states. Such dedifferentiated melanoma cell states are marked by loss of melanocyte specific gene expression and increase of mesenchymal markers. Two crucial transcription factors, MITF and SOX10, important in melanoma development and progression have been implicated in this process. In this study we describe that loss of MITF is associated with a distinct transcriptional program, MITF promoter hypermethylation and poor patient survival in metastatic melanoma. From a comprehensive collection of melanoma cell lines, we observed that MITF methylated cultures were subdivided in two distinct subtypes. Examining mRNA levels of neural crest associated genes we found that one subtype had lost the expression of several lineage genes including SOX10. Intriguingly, SOX10 loss was associated with SOX10 gene promoter hypermethylation and distinct phenotypic and metastatic properties. Depletion of SOX10 in MITF methylated melanoma cells using CRISPR/Cas9 confirmed these findings. In conclusion, this study describes the significance of melanoma state and the underlying functional properties explaining the aggressiveness of such states.
(Less)
- author
- organization
-
- Melanoma
- LUCC: Lund University Cancer Centre
- Melanoma Genomics (research group)
- Division of Clinical Genetics
- The genetics of soft tissue tumors (research group)
- Experimental oncology (research group)
- Division of Translational Cancer Research
- Lund Melanoma Study Group (research group)
- Surgery (Lund)
- Epilepsy Center
- EpiHealth: Epidemiology for Health
- Cellular Neurophysiology and Epilepsy group (research group)
- Neurology, Lund
- publishing date
- 2022-10-10
- type
- Contribution to journal
- publication status
- published
- subject
- in
- JCI Insight
- volume
- 7
- issue
- 19
- article number
- e156577
- publisher
- The American Society for Clinical Investigation
- external identifiers
-
- scopus:85139571437
- pmid:36040798
- ISSN
- 2379-3708
- DOI
- 10.1172/jci.insight.156577
- language
- English
- LU publication?
- yes
- id
- f02b5045-f4be-4dfb-aee5-55cacc486133
- date added to LUP
- 2022-09-07 16:20:02
- date last changed
- 2025-03-07 21:26:47
@article{f02b5045-f4be-4dfb-aee5-55cacc486133, abstract = {{<p>Cellular stress contributes to the capacity of melanoma cells to undergo phenotype switching into highly migratory and drug tolerant dedifferentiated states. Such dedifferentiated melanoma cell states are marked by loss of melanocyte specific gene expression and increase of mesenchymal markers. Two crucial transcription factors, MITF and SOX10, important in melanoma development and progression have been implicated in this process. In this study we describe that loss of MITF is associated with a distinct transcriptional program, MITF promoter hypermethylation and poor patient survival in metastatic melanoma. From a comprehensive collection of melanoma cell lines, we observed that MITF methylated cultures were subdivided in two distinct subtypes. Examining mRNA levels of neural crest associated genes we found that one subtype had lost the expression of several lineage genes including SOX10. Intriguingly, SOX10 loss was associated with SOX10 gene promoter hypermethylation and distinct phenotypic and metastatic properties. Depletion of SOX10 in MITF methylated melanoma cells using CRISPR/Cas9 confirmed these findings. In conclusion, this study describes the significance of melanoma state and the underlying functional properties explaining the aggressiveness of such states.</p>}}, author = {{Sanna, Adriana and Phung, Bengt and Mitra, Shamik and Lauss, Martin and Choi, Jiyeon and Zhang, Tongwu and Njauw, Ching-Ni Jenny and Cordero, Eugenia and Harbst, Katja and Rosengren, Frida and Cabrita, Rita and Johansson, Iva and Isaksson, Karolin and Ingvar, Christian and Carneiro, Ana and Brown, Kevin and Tsao, Hensin and Andersson, My and Pietras, Kristian and Jönsson, Göran}}, issn = {{2379-3708}}, language = {{eng}}, month = {{10}}, number = {{19}}, publisher = {{The American Society for Clinical Investigation}}, series = {{JCI Insight}}, title = {{DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype}}, url = {{http://dx.doi.org/10.1172/jci.insight.156577}}, doi = {{10.1172/jci.insight.156577}}, volume = {{7}}, year = {{2022}}, }